Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.

25 Sep 2012

Lawmakers spar on Medicare Advantage plans

In a Capitol Hill hearing Friday, Republicans challenged the Obama administration's so-called Medicare Advantage "bonuses."

24 Sep 2012

Valeant purchases QLT’s Visudyne

Valeant Pharmaceuticals International, Inc. announced today that it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration, from QLT Inc.

24 Sep 2012

FDA approves Acton’s AEROSPAN sNDA to treat asthma

Acton Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN (flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.

21 Sep 2012

QPharma launches Compliance Advantage solution

QPharma, Inc. has announced the launch of its Compliance Advantage solution, a set of tools and methodologies to streamline compliance and validation activities for life science companies implementing enterprise application systems.

21 Sep 2012

Titan Spine receives U.S. patent for competitive interbody devices

Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has been awarded patent #US 8,262,737 B2 by the United States Patent Office that protects the Company against competitive interbody devices with a roughened surface topography, anti-expulsion edges, and access to a hollow center.

21 Sep 2012

Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its Molecular Biology Center of Excellence in Vilnius, Lithuania.

From Thermo Fisher Scientific Inc. 20 Sep 2012

Wockhardt receives FDA marketing approval for Lansoprazole

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.

17 Sep 2012

Dynamic optical projection stereolithography can rapidly fabricate microscale 3D structures

Nanoengineers at the University of California, San Diego have developed a novel technology that can fabricate, in mere seconds, microscale three dimensional (3D) structures out of soft, biocompatible hydrogels.

14 Sep 2012

Longer looks: The smells to treat PTSD; Nudging healthy choices; When a disabled daughter was shunned

On an Orlando college campus, veterans and active duty soldiers suffering from post-traumatic stress disorder inhale the unmistakable smell of burning tires, rotting garbage and Middle Eastern spices as part of a virtual reality treatment for the psychological wounds of war. Participants sit in a chair wearing a head-mounted display and video goggles connected to a computer system and a scent machine that puffs out the odors, recreating their memories of war.

14 Sep 2012

Patheon third quarter revenues increase to $203.7 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today fiscal 2012 third quarter and nine month results.

13 Sep 2012

Pathogens and Global Health highlights current debate on counterfeit medicine

The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.

13 Sep 2012

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.

13 Sep 2012

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

Pfizer Inc., the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, today announced the launch of Hisun-Pfizer Pharmaceuticals Co., Ltd., a joint venture formed between the two companies to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

13 Sep 2012

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

12 Sep 2012

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics against nosocomial infections.

11 Sep 2012

Polysaccharopeptide improves survival in dogs with hemangiosarcoma

Dogs with hemangiosarcoma that were treated with a compound derived from the Coriolus versicolor mushroom had the longest survival times ever reported for dogs with the disease.

11 Sep 2012

CSL Biotherapies receives U.S. Government contract to supply pandemic vaccine antigens

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced it has been awarded a contract by the United States (U.S.) Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.

11 Sep 2012

Jazz Pharmaceuticals receives new U.S. patent for Xyrem oral solution

Jazz Pharmaceuticals plc. today announced that a new patent related to Xyrem (sodium oxybate) oral solution titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy" will issue today.

11 Sep 2012

MRI workers experience transient neurocognitive effects

Individuals working in the vicinity of magnetic resonance imaging machines may experience transient neurocognitive effects when moving their heads, research demonstrates.

10 Sep 2012

Manufacturing News and Research

Further Reading

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Lawmakers spar on Medicare Advantage plans

Valeant purchases QLT’s Visudyne

FDA approves Acton’s AEROSPAN sNDA to treat asthma

QPharma launches Compliance Advantage solution

Titan Spine receives U.S. patent for competitive interbody devices

Thermo Fisher Scientific announces opening of Molecular Biology Center of Excellence in Lithuania

Wockhardt receives FDA marketing approval for Lansoprazole

Dynamic optical projection stereolithography can rapidly fabricate microscale 3D structures

Longer looks: The smells to treat PTSD; Nudging healthy choices; When a disabled daughter was shunned

Patheon third quarter revenues increase to $203.7 million

Pathogens and Global Health highlights current debate on counterfeit medicine

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Polysaccharopeptide improves survival in dogs with hemangiosarcoma

CSL Biotherapies receives U.S. Government contract to supply pandemic vaccine antigens

Jazz Pharmaceuticals receives new U.S. patent for Xyrem oral solution

MRI workers experience transient neurocognitive effects

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News